25% of candidates passed this question.

It was expected the answer would provide a structured approach to describing the pharmacodynamics (what the drug does to the body) of this discreet class of drugs. A brief acknowledgement of the drugs in this class followed by a catalogue of the various clinical uses of this class of drugs would be a good start. If this was followed up with a description of the effects of these drugs on the CVS, GIT, Salivary glands, eye, NMJ and the lungs a good mark would have been awarded.
A number of candidates described the actions at the receptors in detail which did not attract marks. The extensive range of clinical uses for this class of drugs was poorly appreciated.
Few answers demonstrated any understanding of the PD effects of the drug class. There was generally a good knowledge of representative drugs within this class. Failing to achieve a pass mark reflected scant/brief answers that just did not cover enough of the expected material.